Asami T, Uchiyama M
Division of Paediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Acta Paediatr. 2004 Jan;93(1):22-4. doi: 10.1080/08035250310007259.
Early observations emphasized the possible development of hyponatraemia in hypothyroid children and adults, but recently this has been questioned.
To investigate whether hyponatraemia develops in hypothyroid status by examining sodium handling in screening-detected neonates and infants with congenital hypothyroidism (CH).
Serum thyroid-stimulating hormone (TSH), free thyroxine (FT4), sodium (Na), creatinine (Cr), urinary Na, Cr, fractional sodium excretion rate (FENa) and other chemicals were measured before and after L-thyroxine (LT4) replacement therapy in 32 screening-detected CH neonates (11M, 21F) and 16 age-matched control neonates.
No cases of hyponatraemia were found in the 32 CH neonates. Their serum Na concentrations (139.1 +/- 1.5 mmol/L, ranging from 136 to 142 mmol/L, median 139 mmol/L) were not statistically different from those of 16 control neonates (139.3 +/- 1.3 mmol/L, ranging from 137 to 142 mmol/L, median 139 mmol/L). No correlation was found between serum levels of TSH and FT4 and serum Na or FENa. No significant changes were found in serum Na concentrations in hypothyroid neonates two months after LT4 replacement therapy. The serum Na concentration (139.1 +/- 0.3 mmol/L, n = 25) before treatment did not change statistically (138.9 +/- 0.2 mmol/L, n = 25) two months after LT4 replacement therapy.
As seen in various earlier reports, hyponatraemia can occur in hypothyroid patients, but no causal relationship exists between them. When hyponatraemia is detected in hypothyroid children, it does not seem to be directly related to lack of thyroid hormones and therefore other possible causes should be sought.
早期观察强调甲状腺功能减退的儿童和成人可能发生低钠血症,但最近对此提出了质疑。
通过检查筛查发现的先天性甲状腺功能减退症(CH)新生儿和婴儿的钠处理情况,研究甲状腺功能减退状态下是否会发生低钠血症。
在32例筛查发现的CH新生儿(11例男性,21例女性)和16例年龄匹配的对照新生儿中,测量左旋甲状腺素(LT4)替代治疗前后的血清促甲状腺激素(TSH)、游离甲状腺素(FT4)、钠(Na)、肌酐(Cr)、尿Na、Cr、钠排泄分数率(FENa)及其他化学物质。
32例CH新生儿中未发现低钠血症病例。他们的血清Na浓度(139.1±1.5 mmol/L,范围为136至142 mmol/L,中位数139 mmol/L)与16例对照新生儿(139.3±1.3 mmol/L,范围为137至142 mmol/L,中位数139 mmol/L)无统计学差异。TSH和FT4的血清水平与血清Na或FENa之间未发现相关性。LT4替代治疗两个月后,甲状腺功能减退新生儿的血清Na浓度无显著变化。治疗前血清Na浓度(139.1±0.3 mmol/L,n = 25)在LT4替代治疗两个月后无统计学变化(138.9±0.2 mmol/L,n = 25)。
如各种早期报告所示,甲状腺功能减退患者可发生低钠血症,但两者之间不存在因果关系。当在甲状腺功能减退儿童中检测到低钠血症时,似乎与甲状腺激素缺乏无直接关系,因此应寻找其他可能的原因。